# The Effect of PAS on the Pharmacokinetics of Tenofovir in Healthy Subjects

> **NCT03070405** · PHASE1 · UNKNOWN · sponsor: **Inje University** · enrollment: 20 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Tenofovir disoproxil fumarate 300mg
- **DRUG:** Para-aminosalicylic acid Ca granule 5.28 g

## Key facts

- **NCT ID:** NCT03070405
- **Lead sponsor:** Inje University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10
- **Primary completion:** 2017-03
- **Final completion:** 2017-05
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2017-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03070405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03070405, "The Effect of PAS on the Pharmacokinetics of Tenofovir in Healthy Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03070405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*